Targeting mutant p53 by a SIRT1 activator YK-3-237 inhibits the proliferation of triple-negative breast cancer cells.
2013-07-16

2013. Yi YW, Kang HJ, Kim HJ, Kong Y, Brown ML, Bae I. Oncotarget 4(7): 984-94.